BioLineRx | Driving innovative therapeutics across the finish line
BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 4.643 |
| 2025-04 | 3.564 |
| 2025-05 | 2.928 |
| Source | Traffic Share |
|---|---|
| search | 43.44% |
| direct | 42.25% |
| social | 6.92% |
| referrals | 6.39% |
| paid referrals | 0.89% |
| 0.11% |
| Region | Percentage |
|---|---|
| United States | 41.62% |
| IL | 33.06% |
| ES | 24.90% |
| India | 0.42% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| biolinerx | 38 | 380 | $0.00 |
| motixafortide (aphexda) low risk myelodysplastic biolinerx | 4 | 40 | $0.00 |
| blrx | 80 | 800 | $1.20 |
| blrx stock website | 2 | 20 | $0.00 |
| finish line careers | 207 | 2,070 | $1.65 |